Trial reportEuropean journal of nuclear medicine and molecular imaging2022
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial.
Trial report in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02208544 (Efficacy of [18F]-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy of [18F]-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography (FDG-PET) in Evaluation of Cytological Indeterminate Thyroid Nodules Prior to Surgery: a Multicentre Cost-effectiveness Study
Who cites it
13 citing papers in PubMed, 22 citations in OpenAlex.
- Molecular Diagnostics and [Thyroid : official journal of the American Thyroid Association · 2024Trial
- The MIBI is dead, long live the MIBI: revisiting [99mTc]Tc-Sestamibi thyroid scintigraphy in the era of ultrasound, cytology, molecular diagnostic, and 18 F-FDG PET/CT.European journal of nuclear medicine and molecular imaging · 2026Article
- Combined use of 18 F-FDG PET/CT and MRI for evaluating infection status and clinical outcomes before reimplantation in two-stage revision arthroplasty.Journal of orthopaedic surgery and research · 2026Article
- Model-based cost-effectiveness studies in nuclear medicine: an unavoidable fact of life.European journal of nuclear medicine and molecular imaging · 2025Article
- Article
- Role of [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024Review
- Cost-effectiveness of one-stop-shop [European journal of nuclear medicine and molecular imaging · 2024Article
- Endocrinology application of molecular imaging: current role of PET/CT.Journal of endocrinological investigation · 2024Review
- Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review.Endocrine · 2024Review
- Integrated Diagnostics of Thyroid Nodules.Cancers · 2024Review
- Preoperative stratification of cytologically indeterminate thyroid nodules by [European journal of nuclear medicine and molecular imaging · 2023Article
- PET/CT May Assist in Avoiding Pointless Thyroidectomy in Indeterminate Thyroid Nodules: A Narrative Review.Cancers · 2023Review
- Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules.Endocrine connections · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate cost-effectiveness of an [
methodsLifelong societal costs and quality-adjusted life years (QALYs) were assessed for 132 patients participating in a randomised controlled multicentre trial comparing [
resultsThe observed 1-year cost difference of [
conclusionFollowing the observed reduction in diagnostic surgery, an [ TRIAL REGISTRATION NUMBER: This trial is registered with ClinicalTrials.gov: NCT02208544 (5 August 2014), https://clinicaltrials.gov/ct2/show/NCT02208544 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.